Moderna Launches Another mRNA-Based Injection Targeting The Common Cold RSV

The genie of mRNA gene therapy injections is out of the bottle. Moderna’s new shot targets the common cold RSV, an extremely low-risk virus, and the FDA has granted fast-track designation for rapid approval.
This new shot will mostly target young children and older adults. No other RSV vaccine has ever been successful. Why the rush to saturate the human race with genetically modified injections designed to hack the immune system? ⁃ TN Editor> Respiratory syncytial virus (RSV) &mda